EUVIMEDEUVIMED entdecken
Crossref

Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis

Eun-Jin Go iD, Hannah Yang iD, Wooram Park iD, Seung Joon Lee, Jun-Hyeok Han, So Jung Kong, Won Suk Lee iD, Dong Keun Han iD, Hong Jae Chon iD, Chan Kim iD

Small · 2023-10 · 19 (43)

DOI: 10.1002/smll.202300544 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small, online erschienen am 28.06.2023. Verfasst von Eun-Jin Go und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea. Hauptthemen laut MEDLINE: Liposomes, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 56 Literaturangaben. Gefördert von: National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although stimulator of interferon genes (STING) agonists has shown great promise in preclinical studies, the clinical development of STING agonist therapy is challenged by its limited systemic delivery. Here, positively charged fusogenic liposomes loaded with a STING agonist (PoSTING) are designed for systemic delivery and to preferentially target the tumor microenvironment. When PoSTING is administered intravenously, it selectively targets not only tumor cells but also immune and tumor endothelial cells (ECs). In particular, delivery of STING agonists to tumor ECs normalizes abnormal tumor vasculatures, induces intratumoral STING activation, and elicits robust anti‐tumor T cell immunity within the tumor microenvironment. Therefore, PoSTING can be used as a systemic delivery platform to overcome the limitations of using STING agonists in clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesNeoplasmsHumansTumor MicroenvironmentEndothelial CellsNeovascularization, PathologicImmunotherapy

Stichwörter der Autor:innen

Immunotherapypositively charged liposomesstimulator of interferon genes (STING)systemic deliverytumor angiogenesisvascular normalization

Substanzen

Liposomes

Autor:innen und Institutionen

  • Medical Oncology, CHA Bundang Medical Center, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea.
  • Laboratory of Translational Immuno-Oncology, CHA University School of Medicine, Seongnam, Gyeonggi, 13496, Republic of Korea.
  • Department of Integrative Biotechnology, College of Biotechnology and Bioengineering, Sungkyunkwan University, Seoburo 2066, Suwon, Gyeonggi, 16419, Republic of Korea.
  • Department of Biomedical Science, CHA University, Seongnam, Gyeonggi, 13496, Republic of Korea.

ORCID-Profile: Eun-Jin Go, Hannah Yang, Wooram Park, Won Suk Lee, Dong Keun Han, Hong Jae Chon, Chan Kim

Förderung

  • National Research Foundation of Korea

Zitieren

APA

Go, E. J., Yang, H., Park, W., Lee, S. J., Han, J. H., Kong, S. J., Lee, W. S., Han, D. K., Chon, H. J., & Kim, C. (2023). Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small, 19(43). https://doi.org/10.1002/smll.202300544

Vancouver

Go EJ, Yang H, Park W, Lee SJ, Han JH, Kong SJ, et al. Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis. Small. 2023;19(43). doi:10.1002/smll.202300544

BibTeX
@article{Go2023,
  author = {Go, Eun-Jin and Yang, Hannah and Park, Wooram and Lee, Seung Joon and Han, Jun-Hyeok and Kong, So Jung and Lee, Won Suk and Han, Dong Keun and Chon, Hong Jae and Kim, Chan},
  title = {Systemic Delivery of a STING Agonist‐Loaded Positively Charged Liposome Selectively Targets Tumor Immune Microenvironment and Suppresses Tumor Angiogenesis},
  journal = {Small},
  year = {2023},
  volume = {19},
  number = {43},
  doi = {10.1002/smll.202300544}
}
Kostenlos starten →